Skip to content

Role of homoeopathic medicine in the treatment of eye allergy in children.

Role of individualized homoeopathic medicine using 50-millisemal potency in reducing total serum immunoglobulin E in cases of allergic conjunctivitis in paediatric age group: A prospective single-arm pre-post assessment interventional study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099392
Enrollment
40
Registered
2025-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H104- Chronic conjunctivitis

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic medicine will be prescribed in 50-millesimal potency after proper case taking. Dose and frequency of the selected medic

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with recurrent episodes of symptoms of allergic conjunctivitis such as itching, tearing and redness of eyes, swelling of the conjunctiva etc. Total serum IgE above the age-specific normal value. Patients parents willing to give written informed consent and the patients willing to give verbal assent (aged between 6-11 years) and/or written assent (aged between 12-18 years). Patients already undergoing conventional treatment or homoeopathic treatment for allergic conjunctivitis may be recruited after a washout period of 1 month.

Exclusion criteria

Exclusion criteria: Patients having severe complications of allergic conjunctivitis like corneal ulceration, cataract etc. Critically ill patien, immunocompromised patient. Patient suffering from any other systemic disease. Diagnosed case of unstable mental or psychiatric illness. Patients with substance abuse.

Design outcomes

Primary

MeasureTime frame
Total Serum Immunoglobulin-E levelTimepoint: Baseline and 6 months

Secondary

MeasureTime frame
Total Occular Symptoms ScoreTimepoint: Baseline and 6 months;Modified Naranjo Criteria for HomeopathyTimepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactDr K VIJAY ANANTH

National Institute of Homoeopathy

vjananth74@gmail.com8584888058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026